Drugs / Sanjie Analgesic Capsule
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02031523 Comparator | Oct 2013 → Oct 2015 | primary dysmenorrhea | Jiangsu Kanion Pharmaceutical Co., Ltd | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sanjie Analgesic Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02031523 ↗ |
| Known as | SAC | “OBJECTIVE: To assess the efficacy and safety of Sanjie Analgesic Capsule (SAC)” PMID 39046647 ↗ Jul 2024 |
| Modality | Traditional medicine (herbal / TCM) | “Sanjie Analgesic Capsule is a Chinese Traditional Patent Medicine.” NCT02031523 ↗ |
| Route | Oral | “1.6 g 3 times per day, orally” PMID 39046647 ↗ Jul 2024 |